PACS Group, Inc. insider Joshua Jergensen reported a series of open-market sales of PACS common stock on July 15, 2026, according to a Form 4 filed July 16. The transactions were coded “S,” indicating sales, and were executed under a Rule 10b5-1 trading plan that Jergensen adopted on March 12, 2026. Jergensen first sold 7,440 shares at a weighted-average price of $44.4983 per share, with the shares sold in multiple transactions ranging from $43.74 to $44.735. After that sale, his reported direct ownership stood at 2,608,880 shares. He then sold an additional 32,327 shares at a weighted-average price of $45.1322 per share. Those sales were also made in multiple transactions, at prices ranging from $44.74 to $45.735 per share. Following that transaction, his reported holdings declined to 2,576,553 shares. The filing also indicates a further small sale of 233 shares on the same date, with the related footnote stating that shares were sold in multiple transactions at prices ranging from $45.75 to $45.78. Based on the sequential ownership figures, Jergensen’s direct beneficial ownership after the reported sales was approximately 2,576,320 shares of PACS common stock. The two larger reported weighted-average sales alone generated about $1.79 million in gross proceeds, before commissions or taxes. Including the 233-share sale, total gross proceeds were roughly $1.8 million. The filing does not report any option exercise, restricted-stock vesting, or derivative-security transaction connected to the sales. The Form 4 was signed on Jergensen’s behalf by John Mitchell, attorney-in-fact, on July 16, 2026.